What are the gastrointestinal manifestations of chronic graft-versus-host disease (GVHD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Gastrointestinal Manifestations of Chronic GVHD

Chronic GVHD primarily affects the upper GI tract with esophageal webs and strictures, while lower GI involvement presents with diarrhea and malabsorption, though isolated chronic GI GVHD is uncommon—most persistent GI symptoms in chronic GVHD patients actually represent ongoing acute GVHD. 1

Upper GI Manifestations

Esophageal involvement is the hallmark of chronic GI GVHD, characterized by:

  • Esophageal webs and strictures visible on endoscopy or barium studies 1
  • Oral involvement (part of the distinctive diagnostic features) 1

These structural changes require endoscopic esophageal dilation for management 2.

Lower GI Manifestations

Diarrhea is the predominant symptom of lower GI chronic GVHD, with several important complications 2:

Malabsorption and Nutritional Deficiencies

  • Pancreatic atrophy leading to fat malabsorption may occur, requiring oral pancreatic enzyme supplementation 2
  • Protein-losing enteropathy with deficiencies of:
    • Trace elements (magnesium, zinc)
    • Vitamins (thiamine, B12, vitamin D) 2

Key Diagnostic Caveat

Despite having chronic GVHD, histologic examination of GI biopsies typically shows acute GVHD changes rather than chronic features 3. In a clinicopathologic study, 59% of chronic GVHD patients with GI symptoms had histologic evidence of acute GI GVHD, while only 14% showed possible chronic changes, and 27% had mixed features 3. This means persistent GI symptoms in chronic GVHD patients usually represent ongoing acute GI inflammation, not true chronic GI GVHD 3.

Histologic Features (When Present)

True chronic intestinal GVHD shows 4:

  • Villous atrophy
  • Glandular lesions with variable apoptosis
  • Lamina propria infiltrate with cytotoxic T lymphocytes (CD3+, CD8+, TiA1+)
  • Fibrosis and significant crypt distortion 3

Imaging Findings

Non-specific radiologic features include 5:

  • Bowel wall thickening with mucosal enhancement
  • Mesenteric edema
  • Vascular engorgement

Clinical Approach

Endoscopic evaluation with biopsies is essential for patients with diarrhea after stem cell transplantation 1. The British Society of Gastroenterology recommends:

  • Small bowel aspiration and biopsies 1
  • Multidisciplinary approach including haematologists, dietitian, gastroenterologists, and specialist symptom control team 1

Maintain a low threshold for investigating new GI symptoms to exclude secondary malignancy, as these patients have increased cancer risk 1.

Important Clinical Pitfall

Do not assume all GI symptoms in chronic GVHD patients are from chronic GI GVHD. Other causes include 3:

  • Ongoing acute GI GVHD (most common)
  • GI dysmotility (18% of cases)
  • Infection
  • Drug side effects
  • Malabsorption from other causes

The distinction matters because treatment approaches differ—acute GVHD requires intensified immunosuppression, while chronic manifestations may benefit from targeted supportive measures like enzyme supplementation and endoscopic dilation.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.